Article
The Onion Problem: Four Ways Biopharma Patent Portfolios Lose Their Layers
In a biopharma patent portfolio, layers matter. The core innovation sits at the center, protected by a composition of matter patent. Around it, successive patent families can protect discoveries made during development: new uses, delivery mechanisms, dosage regimens, solutions to adverse effects, formulations, manufacturing processes and methods of commercialization.
Barnes & Thornburg LLP